Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VascoRx Specialty Pharmacy was a U.S. specialty pharmacy and infusion services company focused on dispensing specialty medications and supporting patients and physicians managing complex chronic and high-acuity conditions. The business served areas such as HIV/AIDS, oncology, hepatitis, transplant, wound care, rheumatology, orthopedics, and dermatology, and operated from Phoenix, Arizona. In May 2023, AleraCare announced that VascoRx Specialty Pharmacy, along with related subsidiaries, would be consolidated under the AleraCare brand as part of a national rebranding. As a result, VascoRx appears to persist primarily as a legacy brand rather than as a currently independent operating company. The company was commercial-stage and service-oriented rather than a therapeutic product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VascoRx Specialty Pharmacy.